Products

About half of the drugs approved for medical therapy in the last two decades have been derivatives of natural substances. In oncology, the use of compounds based on natural precursor molecules is even higher: 74% of all anti-tumor compounds are natural products or have been derived from, or inspired by, a natural product. Examples include vinca alkaloids, taxanes, topoisomerase inhibitors, cytokines and various enzymes. These high numbers are not surprising as natural products have evolved to interact with the machinery or surface of cells and very often can easily enter tissue and cells.
CYTAVIS is connecting to this tradition by focusing on derivatives of natural substances. Compounds include lectins as well as Fredericamycin A derivatives.